Scientist II, Molecular Biology-Cell Line Development
Alloy Therapeutics
Summary
Our Cell Line Development (CLD) team is seeking a Scientist II to join our team in Waltham, Massachusetts in the Antibody-Powered Division. This position is lab-based and will support Alloy's antibody discovery services through the vector design and execution of molecular biology techniques for cell line development workflows.
Job description
About the Role
Our Cell Line Development (CLD) team is seeking a Scientist II to join our team in Waltham, Massachusetts in the Antibody-Powered Division. This position is lab-based and will support Alloy's antibody discovery services through the vector design and execution of molecular biology techniques for cell line development workflows.
We are seeking a highly motivated and innovative Scientist II to be a critical driver of our mammalian cell line development (CLD) processes, blending deep molecular biology expertise with hands-on cell line development workflows. You will lead the design and optimization of genetic vectors for stable transfections while actively executing standard workflows for generating stable CHO cell lines. You will also help run and improve end-to-end CLD workflows.
Key Responsibilities
- Vector Design & Molecular Biology: Design, construct, and optimize complex mammalian expression vectors for therapeutic protein production. Apply advanced molecular cloning techniques, codon optimization, and expression tuning strategies to maximize cellular productivity.
- Cell Line Development Workflows: Execute end-to-end CHO stable cell line development, including stable pool generation, transfection, single-cell cloning, high-throughput clone screening, and stability testing.
- Genetic Engineering: Evaluate and implement advanced cell line technologies, such as targeted integration systems, transposon-based expression, novel selection markers, and host cell engineering.
- Data & Analytics: Utilize DNA design software (e.g., Geneious Prime) for construct validation and sequence analysis. Run basic downstream quality assays and assess cellular parameters governing gene integration, transcription, and protein secretion.
- Cross-Functional Collaboration: Communicate experimental designs, progress, and results clearly to stakeholders, management, and partners to drive critical path decisions.
- Documentation & Compliance: Maintain detailed electronic laboratory notebooks (ELN), author technical reports, and ensure development activities are well-documented to support future regulatory filings (e.g., ICH Q5D) and technology transfer to manufacturing.
Required Qualifications
- Ph.D with at least two years of relevant industry experience in a pharmaceutical, biotech, or CDMO setting. MS/BS with equivalent extensive industry experience will also be considered.
- Strong foundation in molecular biology, with proven expertise designing and implementing complex genetic constructs and utilizing sequence analysis tools.
- Experience with designing monoclonal, bispecific, and multi-specific constructs.
- Demonstrated hands-on experience in mammalian stable cell line generation (specifically CHO platforms) and general CLD equipment and workflows (e.g., electroporation, single-cell dispensing, clonality documentation).
- Proficiency in aseptic technique and maintaining healthy, reproducible mammalian cell cultures.
- Hands-on experience monitoring cell culture health and metabolic profiles using analyzers such as Vi-CELL BLU, NovaFlex2 or equivalent instrumentation.
- Strong organizational skills with the ability to manage multiple projects and prioritize independently.
- Ability to maintain electronic laboratory notebooks in compliance with industry standards.
- Excellent communication skills, with a track record of taking initiative, driving projects forward with persistence, and fostering productive relationships across teams.
Preferred Qualifications
- Deep familiarity with current technologies for stable integration (e.g., transposases, site-specific integrases etc).
- Experience in copy number assays (ddPCR) is preferred.
- Experience in a client-facing CDMO or PDO environment.
- Familiarity with scale-up considerations, cell banking, and regulatory requirements for biologics production.
- Familiarity with Ambr-15 or Ambr-250 systems.
Requirements
- Ph.D with at least two years of relevant industry experience in a pharmaceutical, biotech, or CDMO setting; MS/BS with equivalent extensive industry experience will also be considered
- Strong foundation in molecular biology with proven expertise designing and implementing complex genetic constructs and utilizing sequence analysis tools
- Experience with designing monoclonal, bispecific, and multi-specific constructs
- Demonstrated hands-on experience in mammalian stable cell line generation (specifically CHO platforms) and general CLD equipment and workflows (e.g., electroporation, single-cell dispensing, clonality documentation)
- Proficiency in aseptic technique and maintaining healthy, reproducible mammalian cell cultures
- Hands-on experience monitoring cell culture health and metabolic profiles using analyzers such as Vi-CELL BLU, NovaFlex2 or equivalent instrumentation
- Strong organizational skills with the ability to manage multiple projects and prioritize independently
- Ability to maintain electronic laboratory notebooks in compliance with industry standards
- Excellent communication skills with a track record of taking initiative, driving projects forward with persistence, and fostering productive relationships across teams
- Deep familiarity with current technologies for stable integration (e.g., transposases, site-specific integrases)
- Experience in copy number assays (ddPCR)
- Experience in a client-facing CDMO or PDO environment
- Familiarity with scale-up considerations, cell banking, and regulatory requirements for biologics production
- Familiarity with Ambr-15 or Ambr-250 systems
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Company-paid Disability & Life Insurance
- Paid Parental Leave
- Family Planning Support
- Unlimited PTO
- Flexible Schedules
- Continuing Education Stipend
- Employee Assistance Program
- Equity Compensation
Company overview
Alloy Therapeutics is a biotechnology ecosystem company founded in 2017 that empowers the global scientific community to make better medicines together. Headquartered in Boston, Massachusetts with additional labs in Cambridge, UK; Basel, Switzerland; and Athens, Georgia, the company democratizes access to foundational drug discovery technologies and services. Alloy provides affordable, non-exclusive access to its innovative platforms and discovery capabilities, serving academic scientists, small and medium biotech companies, and large biopharmaceutical firms. The company's lead offering is the ATX-Gx™ platform, a human therapeutic antibody discovery platform featuring proprietary transgenic mice strains. Alloy has collaborated with over 170 partners, including 18 of the Fortune 50 biopharmaceutical companies, and has contributed to 60+ licensed programs with 9 antibodies currently in clinical development. The company reinvests 100% of its revenue back into innovation and access to innovation, reflecting its commitment to advancing therapeutic discovery across multiple modalities including antibodies, bispecifics, TCR mimics, genetic medicines, and cell therapies.